(Q42963776)

11 November 2017

title

Quantifying the return of headache in triptan-treated migraineurs: an observational study (English)

1 reference

11 November 2017

1 reference

6

Richard B Lipton

1 reference

11 November 2017

Fred Sheftell

1

1 reference

11 November 2017

Mary Almas

2

1 reference

11 November 2017

Randall Weeks

3

1 reference

11 November 2017

Ninan T Mathew

4

1 reference

11 November 2017

Verne Pitman

5

1 reference

11 November 2017

language of work or name

English

0 references

publication date

17 March 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

30

1 reference

11 November 2017

issue

7

1 reference

11 November 2017

page(s)

838-846

1 reference

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Headache recurrence as a criterion for assessing efficacy of triptans: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Applying the benefits of the AwM study in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

What do patients with migraine want from acute migraine treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102409354390

21 January 2018

Identifiers

DOI

10.1177/0333102409354390

1 reference

11 November 2017

1 reference